Vis børsmeldingen
2025, and all Warrants B not exercised within such time lapsed without
compensation to the holder.
A total of 36,767 Warrants B were exercised, resulting in an aggregate
subscription for 36,767 new shares (the “New Shares”) in the Company, each
Warrant B having an exercise price of NOK 0.15.
The Board of Directors of the Company has approved the allocation of New Shares
to the exercising holders of Warrants B and has consequently resolved to
increase the share capital of the Company.
Payment for the allocated New Shares falls due one week after the Board’s
resolution. The New Shares will be issued upon registration of the share capital
increase in the Norwegian Register of Business Enterprises.
Following registration of the share capital increase in connection with the
exercise of Warrants B, the Company’s share capital will be NOK 38,316,309.99,
divided into 3,831,630,999 shares each with a nominal value of NOK 0.01.
For more information relating to the Warrants, please refer to the Prospectus
approved and published by the Company on 13 November 2024.
For further information contact:
Kristian Flaten, CFO, Tel: +47 95092322
E-mail: ir@idexbiometrics.com (mailto:ir@idexbiometrics.com)
About IDEX Biometrics:
IDEX Biometrics ASA ( IDEX) is a global technology leader in fingerprint
biometrics, offering authentication solutions across payments, access control,
and digital identity. Our solutions bring convenience, security, peace of mind
and seamless user experiences to the world. Built on patented and proprietary
sensor technologies, integrated circuit designs, and software, our biometric
solutions target card-based applications for payments and digital
authentication. As an industry-enabler we partner with leading card
manufacturers and technology companies to bring our solutions to market. For
more information, visit www.idexbiometrics.com .
About this notice:
This notice was published by Kristian Flaten, CFO, 5 May 2025 at 23:35 CET on
behalf of IDEX Biometrics ASA. This information is subject to the disclosure
requirements pursuant to the Norwegian Securities Trading Act section 5-12.
Kilde